Eunok Paek

Dr. Eunok Paek

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Cancer Cell
Verified
Journal Article
Closed access
DMDong-Gi Mun
Dong-Gi Mun
JBJinhyuk Bhin
Jinhyuk Bhin
SKSangok Kim
Sangok Kim
HKHyunwoo Kim
Hyunwoo Kim
JJJae Hun Jung
Jae Hun Jung
DHDaehee Hwang
Daehee Hwang

1 April 2012 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
SNSeungjin Na
Seungjin Na
NBNuno Bandeira
Nuno Bandeira
EPEunok Paek
Eunok Paek
With great biological interest in post-translational modifications (PTMs), various approaches have been introduced to identify PTMs using MS/MS. Recent developments for PTM identification have focused on an unrestrictive approach that searches MS/MS spectra for all known and possibly even unknown types of PTMs at once. However, the resulting expanded search space requires much longer search time and also increases the number of false positives (incorrect identifications) and false negatives (missed true identifications), thus creating a bottleneck in high throughput analysis. Here we introduce MODa, a novel “multi-blind” spectral alignment algorithm that allows for fast unrestrictive PTM searches with no limitation on the number of modifications per peptide while featuring over an order of magnitude speedup in relation to existing approaches. We demonstrate the sensitivity of MODa on human shotgun proteomics data where it reveals multiple mutations, a wide range of modifications (including glycosylation), and evidence for several putative novel modifications. Based on the reported findings, we argue that the efficiency and sensitivity of MODa make it the first unrestrictive search tool with the potential to fully replace conventional restrictive identification of proteomics mass spectrometry data.

3 July 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
SOSejin Oh
Sejin Oh
JYJeongHun Yeom
JeongHun Yeom
HCHee Jin Cho
Hee Jin Cho
JKJu-Hwa Kim
Ju-Hwa Kim
SYSeon-Jin Yoon
Seon-Jin Yoon
HKHyun Seok Kim
Hyun Seok Kim
The prognostic and therapeutic relevance of molecular subtypes for the most aggressive isocitrate dehydrogenase 1/2 (IDH) wild-type glioblastoma (GBM) is currently limited due to high molecular heterogeneity of the tumors that impedes patient stratification. Here, we describe a distinct binary classification ofIDHwild-type GBM tumors derived from a quantitative proteomic analysis of 39IDHwild-type GBMs as well asIDHmutant and low-grade glioma controls. Specifically, GBM proteomic cluster 1 (GPC1) tumors exhibit Warburg-like features, neural stem-cell markers, immune checkpoint ligands, and a poor prognostic biomarker, FKBP prolyl isomerase 9 (FKBP9). Meanwhile, GPC2 tumors show elevated oxidative phosphorylation-related proteins, differentiated oligodendrocyte and astrocyte markers, and a favorable prognostic biomarker, phosphoglycerate dehydrogenase (PHGDH). Integrating these proteomic features with the pharmacological profiles of matched patient-derived cells (PDCs) reveals that the mTORC1/2 dual inhibitor AZD2014 is cytotoxic to the poor prognostic PDCs. Our analyses will guide GBM prognosis and precision treatment strategies.

2 June 2014 in Mass Spectrometry Reviews
Verified
Journal Article
Closed access
PDF file
SNSeungjin Na
Seungjin Na
EPEunok Paek
Eunok Paek

23 November 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
KSKyu Jin Song
Kyu Jin Song
SCSeunghyuk Choi
Seunghyuk Choi
KKKwoneel Kim
Kwoneel Kim
HHHee Sang Hwang
Hee Sang Hwang
ECEunhyong Chang
Eunhyong Chang
KKKwang Kim
Kwang Kim
Non-small cell lung cancer (NSCLC) is histologically classified into lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LSCC). However, some tumors are histologically ambiguous and other pathophysiological features or microenvironmental factors may be more prominent. Here we report integrative multiomics analyses using data for 229 patients from a Korean NSCLC cohort and 462 patients from previous multiomics studies. Histological examination reveals five molecular subtypes, one of which is a NSCLC subtype with PI3K-Akt pathway upregulation, showing a high proportion of metastasis and poor survival outcomes regardless of any specific NSCLC histology. Proliferative subtypes are present in LUAD and LSCC, which show strong associations with whole genome doubling (WGD) events. Comprehensive characterization of the immune microenvironment reveals various immune cell compositions and neoantigen loads across molecular subtypes, which predicting different prognoses. Immunological subtypes exhibit a hot tumor-enriched state and a higher efficacy of adjuvant therapy.

26 July 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JYJeonghun Yeom
Jeonghun Yeom
SJShinyeong Ju
Shinyeong Ju
YCYunJin Choi
YunJin Choi
EPEunok Paek
Eunok Paek
Cheolju LeeCheolju Lee
Cheolju Lee
Various forms of protein (proteoforms) are generated by genetic variations, alternative splicing, alternative translation initiation, co- or post-translational modification and proteolysis. Different proteoforms are in part discovered by characterizing their N-terminal sequences. Here, we introduce an N-terminal-peptide-enrichment method, Nrich. Filter-aided negative selection formed the basis for the use of two N-blocking reagents and two endoproteases in this method. We identified 6,525 acetylated (or partially acetylated) and 6,570 free protein N-termini arising from 5,727 proteins in HEK293T human cells. The protein N-termini included translation initiation sites annotated in the UniProtKB database, putative alternative translational initiation sites, and N-terminal sites exposed after signal/transit/pro-peptide removal or unknown processing, revealing various proteoforms in cells. In addition, 46 novel protein N-termini were identified in 5′ untranslated region (UTR) sequence with pseudo start codons. Our data showing the observation of N-terminal sequences of mature proteins constitutes a useful resource that may provide information for a better understanding of various proteoforms in cells.